Maxim Group Press Releases
New York (October 23rd, 2009)
Maxim Group LLC Expands Equity Research Department with the Appointment of a Senior China Analyst
Maxim Group LLC, a leading full-service boutique investment banking, securities and wealth management firm today announced the appointment of Dr. Echo Yinghui He, M.D., PhD, as a Senior China Analyst.
"China is an important Research Vertical for Maxim Group and having a professional with Dr. He’s experience will help reinforce our capabilities in this key segment", said Anthony Vendetti, Director of Research at Maxim Group.
Prior to joining Maxim Group, Dr. He was a Director at Oppenheimer & Co (former CIBC, Equity Research) where she conducted equity analysis of small-to-mid cap US-listed Chinese stocks. Previous to Oppenheimer & Co., Dr. He served as a Vice President at CRT Capital Group where she conducted equity and credit analysis of Chinese small-cap, US life science and distressed companies. Dr. He also served as a research scientist at the National Institutes of Health (NIH) where she conducted a part of the Human Genome Project aimed at interpreting diseases and their risks by genetic patterns. Dr. He received a M.D. from Beijing University, a PhD in Medical Sciences from the University of Toledo and a M.B.A. in Finance and Economics from the University of Chicago.